READ MORE: Why you MUST think twice about taking the new Wegovy Pill, by DR PHILIPPA KAYE See more Daily Mail on Google - save us as a Preferred SourceBy CIARAN FOREMAN, HEALTH REPORTER Published: 10:51 BST, 3 July 2026 | Updated: 11:28 BST, 3 July 2026
A month's supply of the 4mg tablets will cost £119 for existing patients and £99 for new patients. The 9mg dose will be priced at £169 and £149 respectively, while the highest 25mg dose will cost £229 for existing patients and £209 for new patients. Those requesting the treatment must complete an online questionnaire detailing information such as their height, weight, ethnicity and medical history. Dr Clair Grainger, GP at Superdrug Online Doctor, said: 'Following regulatory approval, we've seen strong interest in our information register. With prescribing now underway, people can now complete their consultation and access treatment if clinically appropriate, whether that's online, in pharmacy, or in clinic.'Obesity is a complex medical issue, and any treatment will only be prescribed following a thorough clinical assessment against eligibility criteria.' The tablet contains the same active ingredient as the Wegovy injection, semaglutide, which mimics a hormone in the gut released after eating. This, in turn, reduces hunger, and makes patients feel fuller for longer.Adults with a body mass index of more than 30, which is classed as obese, are among those who can be prescribed the pill.It is only available privately at this stage. The tablet can also be given to those with a BMI between 27 and 30 who have a 'weight-related' medical condition.Patients already taking 0.5mg or 1mg doses of injectable Wegovy can switch to the 9mg tablets, while those using the 1.7mg, 2.4mg or 7.2mg injection can move to the 25mg tablets, if medically approved. Anyone switching from injections will need to wait one week after their final jab before starting the tablets. The pill was approved for UK use last month by the Medicines and Healthcare products Regulatory Agency, but that does not mean that the drug is available on the NHS. It is understood that manufacturer Novo Nordisk will meet with the Government to discuss rolling out the pill on the NHS - with the price of the drug thought to be the sticking point. Demand for the tablet is now expected to soar, with experts predicting many people who were reluctant to use injections will be more willing to try an oral alternative.
